CS Paper Radar

Machine Learning for Pre-Culture ESBL Risk Stratification to Guide Empiric Antibiotic Selection: A 12-Hospital Study of Enterobacteriaceae Cultures

Aravind V. Kuruvikkattil, Lalitha Pranathi Pulavarthy, Rashmita Kudamala, Saptarshi Purkayastha

cs.LG stat.AP ·submitted 2026-09-05 08:19 UTC · v1
publishedunusual

Abstract

Empiric antibiotic therapy for suspected ESBL-producing Enterobacteriaceae must be selected 48-72 hours before culture results, forcing clinicians to choose between undertreating resistant infections and overusing carbapenems that drive further resistance. We developed a cost-sensitive XGBoost model predicting an ESBL phenotype (resistance to ceftriaxone, ceftazidime, cefepime or piperacillin-tazobactam) at culture ordering using 45 pre-culture EHR features across 132,955 cultures from 72,217 patients at 12 hospitals (14.41% with the ESBL phenotype). Cultures were partitioned at the patient level. At 90% sensitivity, the model achieved 95.8% NPV, reducing post-test ESBL probability to 4.2%, a threshold that may support safe carbapenem-sparing in non-ICU settings, while sparing 307 of every 1,000 cultures an unnecessary broad-spectrum course at the cost of 14 missed ESBL cases per 1,000. SHAP analysis identified prior ESBL colonization as the dominant predictor, ahead of prior organism burden and neighborhood deprivation; removing deprivation features caused minimal performance loss ($Δ\text{AUROC} = -0.020$), enabling equitable bedside deployment. Discrimination was unchanged under a strict IDSA ESBL-E definition (AUROC 0.766), with specimen type added as a predictor (0.764) and without any class-imbalance correction (0.762), and ranged from 0.71 to 0.78 across organism strata.

Comment
Accepted for presentation at American Medical Informatics Association (AMIA) Annual Symposium 2026

Closest papers

Nearest neighbours by meaning across the whole index.

ARMD-Predict: multi-site machine learning to predict antibiotic resistance before culture results

cs.LG q-bio.QM ·2026-10-06 ·Fateme Nateghi Haredasht, Nicholas P. Marshall, Wenyuan Chen, Lauren N. Cooper, Ziming Wei +15 more
similarity 0.75
Abstract · 31 pages, 4 figures, 2 tables, 7 Extended Data figures, 5 Extended Data tables. Research web applications: https://armd-predict.stanford.edu

Clinicians select empiric antibiotics before culture susceptibility results are available. Electronic health record (EHR) models could inform that choice, but most are developed at a single hospital and transport poorly to others. We developed ARMD-Predict using 7.5 million culture-antibiotic observations from four academic medical centers. One set of models estimates susceptibility to individual antibiotics; a second, hierarchical set predicts the infecting organism and then organism-specific resistance phenotypes. Across 23 pooled susceptibility models evaluated in same-period, patient-grouped test partitions, median area under the receiver operating characteristic curve (AUROC) was 0.77 for inpatient urine and 0.70 for inpatient blood cultures; chronological retraining reduced AUROC by approximately 0.04. At an exploratory threshold with 95% positive predictive value, derived and evaluated on the same test observations, the model identified 55% of ceftriaxone-susceptible inpatient urine observations as suitable for narrower therapy and flagged 60% of ceftriaxone-resistant observations for broader coverage. Organism classifiers achieved top-3 accuracy of 51.3-83.3%; phenotype AUROCs were conditional on the observed organism. Research applications are available at https://armd-predict.stanford.edu. Independent calibration, threshold and end-to-end prospective validation are required before clinical use.

0.21

Routine Blood Tests Outperform CRP for Distinguishing Bacterial From Viral Infection in Children

cs.LG ·2026-09-18 ·Mihaela Demireva, Zhecho Mitev, Djuna Chinareva-Klimentova, Svetoslav Ivanov, Georgi Nalbantov +1 more
similarity 0.60
Abstract

Acute infectious diseases are among the leading causes of medical consultations and hospitalizations in children worldwide. These infections are predominantly caused by viruses or bacteria, yet differentiating between the two remains a common clinical challenge. As a result, pediatricians often default to the safer option of prescribing antibiotics contributing to the growing problem of antimicrobial resistance. The objective is to assess the additional predictive value of CBC towards determining the current infection. This retrospective study used data from 906 pediatric patients aged between 2 and 14 years who were tested positive either for viral or bacterial infection between 2022 and 2026. Inclusion criteria further required availability of CBC results and CRP level measurements. These laboratory parameters as well as age were used as input features for several supervised classification models. Model performance was evaluated using AUC, sensitivity and specificity. The best performing model is XGBoost, which included all features, achieving out of-sample performance of AUC of 81.7% and sensitivity of 70.8%, specificity of 79.2%. All trained models outperform a CRP-based only decision-rule model in terms of AUC. We suggest that the decision to prescribe antibiotics should be based on a number of factors, including but not limited to CBC, some of which are not currently incorporated into routine practice.

0.26

How Compliant is Sepsis Treatment? An Expert-Guided Neuro-symbolic Pipeline for Generating Clinical Compliance Insights

cs.AI cs.SC ·2026-08-12 ·Himanshu Tripathi, Kaushik Roy, Subash Neupane, Shahram Rahimi
published similarity 0.49
Abstract · This has been submitted and accepted in NeSy 2026 (https://2026.nesyconf.org/)

Verifying whether clinical care follows evidence-based protocols is a natural neuro-symbolic problem, yet the safety-critical setting defeats either paradigm alone. We present an expert-guided pipeline that constrains a large language model strictly to semantic normalization, mapping messy drug and microbiology strings onto a fixed clinical vocabulary, while a Sugeno fuzzy inference system reasons over the normalized events. The fuzzy layer encodes eight Surviving Sepsis Campaign bundle rules and replaces binary judgments with graded scores in [0,1]. Applied to 2,438 MIMIC-IV v3.1 sepsis episodes, it surfaces antibiotic timing as the most critical breakdown (mean 0.24, 13% within one hour), Hour-1 underperformance (mean 36.7%), a 51% elevated-lactate drop-off, and descriptive differences in ICU stay across compliance groups (3.8 versus 5.1 days).

0.28

Deep learning-guided discovery reveals the diversity and mutational potential of environmental beta-lactamases

cs.AI q-bio.GN ·2026-11-09 ·Liangjun Ge, Qiandi Gao, Haiming Xu, Zhiwei Qin, Heqian Zhang
unusual similarity 0.49
Abstract

Beta-lactamases are a major mechanism of bacterial resistance to beta-lactam antibiotics; however, their functional diversity and mutational potential in environmental microbial communities remain partially understood. This study aimed to characterize environmental beta-lactamase diversity and investigate how sequence variation influences antibiotic resistance. By integrating protein language model (PLMs) with ensemble learning, we identified more than 46,000 putative beta-lactamases across all four Ambler classes from environmental metagenomes, widely distributed across diverse habitats, with distinct habitat-associated class compositions. The candidates sharing approximately 30% sequence identity with known beta-lactamases conferred resistance to multiple beta-lactam antibiotics when expressed in Escherichia coli. Combining inverse folding model with PLMs further identified mutations that altered resistance profiles, including substitutions that increased resistance to carbapenems. Predicted high-fitness sites exhibited greater natural sequence variability overall, with higher variability in wastewater-derived than ocean-derived enzymes. These findings reveal undercharacterized beta-lactamase diversity and substantial mutational flexibility in environmental microbiomes, providing a basis for investigating their potential contribution to the diversification of antibiotic resistance.

0.24

SepsisFlow: an event-stream foundation model for continuous risk warning and trajectory modelling in ICU sepsis

cs.LG ·2026-11-10 ·Yawen Zhang, Wanzhe Xu, Zhenhua Zhang, Jinyu Wu, Yizhou Zhuang +2 more
hot direction similarity 0.49
Abstract · 50 pages, 6 figures, 2 tables

Sepsis is a leading cause of ICU death with heterogeneous onset and course, yet most warning models predict only whether sepsis will occur, leaving clinicians uncertain of its onset context and early trajectory once an alarm sounds. To answer these questions on one hourly clock from ICU admission, we built SepsisFlow: before onset, it combines a Mamba model pretrained on 2.57 million EHRs with about 1,700 hourly features in gradient-boosted trees to predict 6/12/24-h risk; at onset, it fuses Mamba and tabular encoders via a gated network into continuous patient states defining onset contexts; after onset, it encodes 72-h organ-support and physiological trajectories via an attention bidirectional recurrent network into early courses. For pre-onset warning in MIMIC-IV, SepsisFlow detected more cases than NEWS2, qSOFA, and SIRS at equal alarms, gaining about 8 cases per 100 from hourly updating, while outperforming 16 retrained algorithms and maintaining risk ranking in eICU. At onset, its contexts separated 2% cardiovascular-ICU from 15%-17% other 28-day mortality, and within each context after onset, persistent support carried fivefold higher mortality than de-escalation. SepsisFlow establishes a foundation-model paradigm for continuous risk and trajectory stratification in critical care.

0.21

Sharpness-Aware Minimization (SAM) Improves Classification Accuracy of Bacterial Raman Spectral Data Enabling Portable Diagnostics

cs.LG q-bio.QMstat.ML ·2026-09-16 ·Kaitlin Zareno, Jarett Dewbury, Siamak K. Sorooshyari, Hossein Mobahi, Loza F. Tadesse
published similarity 0.48
Abstract · Accepted for oral presentation at the ICLR 2024 Workshop on Practical ML for Low Resource Settings (PML4LRS)

Antimicrobial resistance is expected to claim 10 million lives per year by 2050, and resource-limited regions are most affected. Raman spectroscopy is a novel pathogen diagnostic approach promising rapid and portable antibiotic resistance testing within a few hours, compared to days when using gold standard methods. However, current algorithms for Raman spectra analysis 1) are unable to generalize well on limited datasets across diverse patient populations and 2) require increased complexity due to the necessity of non-trivial pre-processing steps, such as feature extraction, which are essential to mitigate the low-quality nature of Raman spectral data. In this work, we address these limitations using Sharpness-Aware Minimization (SAM) to enhance model generalization across a diverse array of hyperparameters in clinical bacterial isolate classification tasks. We demonstrate that SAM achieves accuracy improvements of up to 10.5% on a single split, and an increase in average accuracy of 2.7% across all splits in spectral classification tasks over the traditional optimizer, Adam. These results display the capability of SAM to advance the clinical application of AI-powered Raman spectroscopy tools.

0.63

Beyond Benchmark Scores: Auditing Medical Vision-Language Models for Chest X-Ray Tuberculosis Screening

cs.CV cs.LG ·2026-09-18 ·Mushir Akhtar, M. Tanveer, Mohd. Arshad
benchmark similarity 0.48
Abstract · 27 pages, 7 figures, and 21 tables; includes extended methods, statistical analyses, and robustness evaluations

A medical model's benchmark score does not establish that the same conclusion holds under a different evaluation. This study tests whether claims about model ranking, score reliability and screening performance survive changes in cohort, prompt, negative spectrum, specified prevalence and operating threshold. We audit three medical vision-language models (BioMedCLIP, CheXficient, and MedSigLIP) and a general-domain OpenCLIP comparator on 12,200 chest radiograph records from four datasets (Montgomery, Shenzhen, TBX11K, and VinDr-CXR). Five fixed prompt families yield 244,000 model--image--prompt scores. No model leads every cohort and reliability criterion. Prompt-family changes alter AUROC in 21 of 48 multiplicity-controlled comparisons. Replacing healthy controls with sick non-tuberculosis controls reduces AUROC by 0.075--0.306 across all four models. On VinDr-CXR, the three medical models distinguish tuberculosis from no-finding controls substantially better than from pneumonia or lung tumor; their AUROC point estimates for both named diseases fall below 0.5. CheXficient has documented VinDr-CXR pretraining exposure, which limits the interpretation of its results. Thresholds chosen for 95\% sensitivity on TBX11K training retain that constraint by point estimate in only four of sixteen target evaluations. A five-seed supervised source model reaches 0.999 AUROC on TBX11K validation but 0.629 on each of two external cohorts. Conservative exclusion of perceptual-overlap candidates narrows this gap without closing it. These retrospective, single-task results show that discrimination, score reliability and threshold retention support different portability claims. Evidence for chest X-ray tuberculosis screening should identify the complete evaluation specification rather than attribute clinical portability to a checkpoint alone.

0.28

DRYLAB-Bench: Benchmarking the Biosecurity Risk of Agentic LLM Mutation Design

cs.AI ·2026-10-09 ·Yuzhen Wang, Chunxiao Li, Baichen Le, Lewen Yan, Jie Zhang +4 more
benchmarkcode/data similarity 0.48
Abstract

As large language models (LLMs) acquire advanced biological design capabilities, they offer substantial research benefits but simultaneously introduce severe dual-use risks, such as engineering enhanced pathogens or drug-resistant bacteria. While biosecurity frameworks recognize these threats, the actual risk of LLMs executing dangerous biological modifications remains unquantified, particularly when augmented with specialized biological design tools (BDTs). Existing evaluations primarily assess hazardous knowledge possession rather than practical application, overlook risk amplification from BDTs, and rely on unreliable, expensive, or hazardous validation methods. To address these gaps, we introduce DRYLAB-Bench (Design Risk Yielded by LLM Agent in Biodesign), the first comprehensive benchmark evaluating the high-risk biological mutation design capabilities of LLM agents. Moving beyond basic question-answering, DRYLAB-Bench tasks agents with 30 genuinely hazardous mutation-design scenarios distilled from biosecurity guidelines. It evaluates models in a multi-round, tool-augmented environment where LLMs orchestrate BDTs to iteratively refine candidates. Crucially, it scores designs directly against 187,695 empirical wet-lab measurements from ProteinGym and ViroGym using our proposed Biosecurity Risk Score (BRS), quantifying risk-associated effects while enabling scalable and safe ground-truth verification. Evaluations of 15 frontier models reveal substantial baseline threats: without tools, 67.6% of one-shot designs exceed the average measured variant, and 21.4% reach the highest-risk decile. Equipping models with BDTs significantly amplifies this risk, raising the pooled risk by \(ΔBRS=+0.116\) and the top-decile share to 23.5%. Code: https://github.com/drylab-bio/DRYLAB-Bench

0.34